Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-04
2011-12-27
Andres, Janet (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S257000
Reexamination Certificate
active
08084471
ABSTRACT:
The present invention relates to compounds, pharmaceutical compositions and methods which inhibit the binding of coactivator proteins in nuclear receptors, including estrogen receptors (alpha and/or beta), androgen receptors, thyroid receptors and peroxisome proliferators-activated receptors, among others. Compounds according to the present invention may be useful in the treatment of a variety of disease states or conditions which are mediated through nuclear receptors.
REFERENCES:
patent: 3838156 (1974-09-01), Brundage et al.
patent: 3920821 (1975-11-01), Schroder et al.
patent: 3937712 (1976-02-01), Schroder et al.
patent: 4294836 (1981-10-01), Lesher et al.
patent: 6200982 (2001-03-01), Collins et al.
patent: 6410729 (2002-06-01), Spohr et al.
patent: 2125310 (1972-11-01), None
patent: 229122 (1992-05-01), None
patent: 2001089452 (2001-04-01), None
Ghozlan et al., Tetrahedron, 58(2002), pp. 9423-9429.
Nantka-Namirski et al., Acta Poloniae Pharmaceutica (1977), 34(2), 133-8.
Zayed et al., Journal of Heterocyclic Chemistry (1983), 20(1), 129-31.
Attia et al., Acta Chimica Hungarica (1983), 112(1), 89-98.
Shiao et al., Heterocycles (1990), 31(4), 637-41.
Breast cancer research, Research page: a new class of drugs to treat breast cancer (2000), pp. 1-3.
Abdelrahmani et al., Cardiovascular research (2005), vol. 65, pp. 772-781.
Arany et al., Nature (2008), vol. 451, pp. 1008-1013.
Becerril Jorge
Hamilton Andrew
Andres Janet
Coleman Henry D.
Rahmani Niloofar
Sapone William J.
Sudol R. Neil
LandOfFree
Proteomimetic compounds as inhibitors of the interaction of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteomimetic compounds as inhibitors of the interaction of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteomimetic compounds as inhibitors of the interaction of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4297760